Search

Search Constraints

You searched for: Author/Creator Isaacson, Stuart H.

Search Results

1. AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions. (2021)

3. Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective. (4th March 2017)

5. Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson's disease starting transdermal rotigotine patch: A pilot study. (July 2019)

6. Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study. (2022)

7. Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients. (June 2021)

8. Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel. Issue 4 (11th March 2023)

9. Frequency of non-motor symptoms in Parkinson's disease patients carrying the E326K and T369M GBA risk variants. (February 2023)

10. Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies. (March 2022)